NIMG-01. DIFFUSION MRI PHENOTYPES PREDICT OVERALL SURVIVAL BENEFIT FROM ANTI-VEGF MONOTHERAPY IN GLIOBLASTOMA AT FIRST OR SECOND RELAPSE

Anti-VEGF therapies remain controversial in the treatment of recurrent GBM. In the current study we demonstrate that recurrent GBM patients with a specific diffusion MR imaging signature have an OS advantage when treated with anti-VEGF therapy at first or second recurrence. These findings were then...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Ellingson, Benjamin, Gerstner, Elizabeth, Smits, Marion, Huang, Ray, Colen, Rivka, Abrey, Lauren, Aftab, Dana, Schwab, Gisela, Hessel, Colin, Gahrmann, Renske, Pope, Whitney, de Groot, John, Wen, Patrick, Batchelor, Tracy, van den Bent, Martin, Cloughesy, Timothy F
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2017
Aiheet:
Abstracts
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692227/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.582
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia